EFTA01394761.pdf
dataset_10 PDF 159.8 KB • Feb 4, 2026 • 1 pages
GLDUS140 Lawrence Hirsch
GP-led transactions can present an attractive risk-reward profile
Glendower Capital has been active since 2007 in this space
GP-Led transactions have significantly evolved over the last 5 years
- Deals in the early days were often associated with (quasi) zombie GPs and were not always crafted in the best interest of existing LPs
- Today, quality managers are proactively providing liquidity options to their LPs, often with an advisor retained to validate the process
GP-led opportunities can present a number of advantages over a traditional acquisition of a LP interest
- An accretive and complementary strategy to the mainstream secondary dealflow
- Glendower has developed an extensive track record' over 15 transactions with gross c.1.6x MOIC / 22% Gross IRR2
- In-depth due diligence on GPs and their teams
- In-depth due diligence on concentrated portfolios, including onsite meetings with underlying companies' management teams
- Bespoke design of a new fund and its terms to provide full re-alignment of interests between the GP and Glendower:
Budgeted fees, significant GP co-investment, and ratcheted carried interest structure
- Incentivisation / protection of specific individuals within the GP that are key to generate value in the existing portfolio
Negative governance rights, including veto rights on add-on investments, recapitalizations, etc.
- Limited to no use of leverage / deferred structures
- underwriting returns based on attractive entry price and portfolio value creation
t I) As ct September 3 2017. Performance figures have been criculaed based on tea re-audited performance results and should be read and revieeed in constiction vrkh the -important Inforrnatr.i.n" and 'Wes to the
Investment Performance' sections of this presentation, I he 'Notes to Investment Perfomtanee section in particular includes. among other things. a description of the terms used in the tables above and sets forth
imrxgrard guidelleas and limaatiors este the nerformanoe described alone Past performance rag a isrediction of the blurs Derto4reterte.
(2 Please refer to the overall tiansaction summaries for SOF, SOF O, SOF II and SOF III on pages 43. 45 and 47.
Glendower STRICTLY CONFIDENTIAL
Capital
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0100803
CONFIDENTIAL SDNY_GM_00246987
EFTA01394761
Entities
0 total entities mentioned
No entities found in this document
Document Metadata
- Document ID
- 7956b0e5-e0f5-4071-b095-0d81c57c7c60
- Storage Key
- dataset_10/2549/EFTA01394761.pdf
- Content Hash
- 2549e436436d93fd5a6e46d59b09b401
- Created
- Feb 4, 2026